Moyamoya disease is a rare cause of stroke, radiologically characterised by progressive
stenosis of the terminal portion of the internal carotid arteries and compensatory capillary …

Objectives Intracranial vessel wall enhancement (VWE) on high-resolution magnetic
resonance imaging (HRMRI) is associated with the progression and poor prognosis of …

Neurocognitive impairment in moyamoya disease is common, under recognized, and
potentially devastating. The purpose of this paper is to provide an updated overview on this …

OBJECTIVE This study aimed to explore the clinical features of moyamoya disease (MMD)
and the efficacy of encephaloduroarteriosynangiosis (EDAS) in elderly patients with MMD …

Objective Prevention of rebleeding events is crucial for patients with hemorrhagic
moyamoya disease (MMD), as these increase the risk of mortality. Bypass surgery is …

Background We aimed to comprehensively analyze the epidemiology, natural history, stroke
events and their risk factors, and the RNF213 p. Arg4810Lys variant in older patients with …

Simple Summary Neurofibromatosis type 1 and Moyamoya disease can be associated in
Moyamoya syndrome (MMS), which causes cerebral arteriopathy consisting of a progressive …

Objective The present study aims to determine whether angiographic differences increase
the risk of ischemic pattern among adult patients with moyamoya disease (MMD). Methods …

Moyamoya disease (MMD) is a chronic, progressive cerebrovascular occlusive disease.
Ring finger protein 213 (RNF213) is a susceptibility gene of MMD. Previous studies have …

Objective Cerebrovascular events in moyamoya disease are mainly classified into ischemic
or hemorrhagic onset. It is rare for one patient to develop both ischemia and hemorrhage in …